ClinicalTrials.gg
Sign In

Hyperlipoproteinemias clinical trials

The registry lists 34 studies for Hyperlipoproteinemias across more than 10 countries. 5 are recruiting or about to start. 17 of them are mainly about Hyperlipoproteinemias (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 3 narrower conditions too, such as Hyperlipoproteinemia Type II: 338 studies, 69 open.

Get an email when these change. Save the Hyperlipoproteinemias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
23
Recruiting
3
Terminated
2
Not yet recruiting
2
No longer available
1
Approved for marketing
1

Phase

Phase 2
11
Phase 3
11
Phase 1
4
Phase 4
3

Where

United States
12
Canada
9
Germany
6
Poland
5
United Kingdom
5
China
5

Who runs them

Zhejiang University (4) · Akcea Therapeutics (3) · Novartis Pharmaceuticals (3) · Kastle Therapeutics, LLC (3) · National Heart, Lung, and Blood Institute (NHLBI) (2) · S.LAB (SOLOWAYS) (2) · Editas Medicine, Inc. (1) · Ionis Pharmaceuticals, Inc. (1)

What is being tested here

Drugs under test in Hyperlipoproteinemias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Zodasiran111
Coenzyme A034
Mipomersen023
Vupanorsen002
Pradigastat012
Pelacarsen012
TA-8995011
Solbinsiran001
Pelacarsen sodium001
Rosuvastatin001

Coming up

1phase 3 study under way
1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Who these studies take

Of the 3 Hyperlipoproteinemias studies recruiting now, 0 (0%) set no upper age limit and 3 (100%) stop at 75 or younger. 1 (33%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.

Recruiting studies that take each age, of 3
AgeWomenMen
100 (0%)0 (0%)
182 (67%)2 (67%)
302 (67%)2 (67%)
402 (67%)2 (67%)
502 (67%)2 (67%)
652 (67%)2 (67%)
750 (0%)0 (0%)
850 (0%)0 (0%)

Across all 34 studies, recruiting or not: 38% stop at 75 or younger and 9% at 65; 21% take children; 0% are for women only and 6% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Stopped1

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 34 of 34. search them.